Tag:
Dow Pharmaceutical Sciences
Latest Headlines
Latest Headlines
Valeant pays $115M for Dow Pharma drug rights
Valeant Pharmaceuticals ( VRX ) is taking steps to free itself from financial obligations as it prepares to move forward with the development of its dermatology pipeline. The drugmaker said today that
Valeant buys Dow in $285M deal
Valeant Pharmaceuticals will beef up its presence in the dermatology field with today's deal to buy Dow Pharmaceutical Sciences for $285 million in cash. The buyout gives Valeant control of the
